Resveratrol reversed chronic restraint stress-induced impaired cognitive function in rats. 2017

Qian Zhang, and Xueer Wang, and Xuemei Bai, and Yunkai Xie, and Tiantian Zhang, and Shishi Bo, and Xiaoyang Chen
Department of Medical Psychology, Shandong University School of Medicine, Jinan, Shandong 250012, P.R. China.

Chronic stress occurs in everyday life, and often results in memory impairments and depressive symptoms. Resveratrol is a natural polyphenol that possesses numerous biological properties, including potent antidepressant‑like effects. The present study aimed to examine the effects of resveratrol treatment on chronic restraint stress (CRS)‑induced cognitive impairment and to explore the underlying molecular mechanisms. Male Wistar rats were exposed to CRS for 21 days in order to induce depressive‑like behavior. The results demonstrated that CRS (6 h/day, 21 days) was able to induce cognitive deficits in rats, as evidenced by Morris water maze and novel object recognition tests. In addition, CRS exposure significantly decreased the mRNA and protein expression levels of hippocampal brain‑derived neurotrophic factor (BDNF) in the rats. Conversely, chronic treatment with resveratrol (80 mg/kg, i.p.; 21 days) significantly prevented the behavioral and biochemical alterations induced by CRS. The effects of resveratrol were nearly identical to those observed with fluoxetine treatment. In conclusion, the present study demonstrated that resveratrol may be a potential therapeutic agent for the treatment of chronic stress‑induced cognitive impairments, and its underlying molecular mechanism may be associated with the increased levels of hippocampal BDNF.

UI MeSH Term Description Entries
D008297 Male Males
D003072 Cognition Disorders Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment. Overinclusion,Disorder, Cognition,Disorders, Cognition
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006624 Hippocampus A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation. Ammon Horn,Cornu Ammonis,Hippocampal Formation,Subiculum,Ammon's Horn,Hippocampus Proper,Ammons Horn,Formation, Hippocampal,Formations, Hippocampal,Hippocampal Formations,Hippocampus Propers,Horn, Ammon,Horn, Ammon's,Proper, Hippocampus,Propers, Hippocampus,Subiculums
D000077185 Resveratrol A stilbene and non-flavonoid polyphenol produced by various plants including grapes and blueberries. It has anti-oxidant, anti-inflammatory, cardioprotective, anti-mutagenic, and anti-carcinogenic properties. It also inhibits platelet aggregation and the activity of several DNA HELICASES in vitro. 3,4',5-Stilbenetriol,3,4',5-Trihydroxystilbene,3,5,4'-Trihydroxystilbene,Resveratrol, (Z)-,Resveratrol-3-sulfate,SRT 501,SRT-501,SRT501,cis-Resveratrol,trans-Resveratrol,trans-Resveratrol-3-O-sulfate,Resveratrol 3 sulfate,cis Resveratrol,trans Resveratrol,trans Resveratrol 3 O sulfate
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant
D001522 Behavior, Animal The observable response an animal makes to any situation. Autotomy Animal,Animal Behavior,Animal Behaviors
D013267 Stilbenes Organic compounds that contain 1,2-diphenylethylene as a functional group. Stilbene,Stilbene Derivative,Stilbene Derivatives,Stilbenoid,Stilbenoids,Derivative, Stilbene,Derivatives, Stilbene

Related Publications

Qian Zhang, and Xueer Wang, and Xuemei Bai, and Yunkai Xie, and Tiantian Zhang, and Shishi Bo, and Xiaoyang Chen
October 2014, Journal of psychiatric research,
Qian Zhang, and Xueer Wang, and Xuemei Bai, and Yunkai Xie, and Tiantian Zhang, and Shishi Bo, and Xiaoyang Chen
March 2023, Biomedical reports,
Qian Zhang, and Xueer Wang, and Xuemei Bai, and Yunkai Xie, and Tiantian Zhang, and Shishi Bo, and Xiaoyang Chen
September 2010, The international journal of neuropsychopharmacology,
Qian Zhang, and Xueer Wang, and Xuemei Bai, and Yunkai Xie, and Tiantian Zhang, and Shishi Bo, and Xiaoyang Chen
September 2021, Neurochemistry international,
Qian Zhang, and Xueer Wang, and Xuemei Bai, and Yunkai Xie, and Tiantian Zhang, and Shishi Bo, and Xiaoyang Chen
October 2002, Life sciences,
Qian Zhang, and Xueer Wang, and Xuemei Bai, and Yunkai Xie, and Tiantian Zhang, and Shishi Bo, and Xiaoyang Chen
April 2007, Neuroscience,
Qian Zhang, and Xueer Wang, and Xuemei Bai, and Yunkai Xie, and Tiantian Zhang, and Shishi Bo, and Xiaoyang Chen
May 2014, Physiology & behavior,
Qian Zhang, and Xueer Wang, and Xuemei Bai, and Yunkai Xie, and Tiantian Zhang, and Shishi Bo, and Xiaoyang Chen
March 2013, Brain research,
Qian Zhang, and Xueer Wang, and Xuemei Bai, and Yunkai Xie, and Tiantian Zhang, and Shishi Bo, and Xiaoyang Chen
July 2015, Behavioural brain research,
Qian Zhang, and Xueer Wang, and Xuemei Bai, and Yunkai Xie, and Tiantian Zhang, and Shishi Bo, and Xiaoyang Chen
January 2005, Neuroscience letters,
Copied contents to your clipboard!